British government ordered 100 million doses of Oxford coronavirus vaccine, and nursing home residents and employees are given priority to vaccination.
According to a large-scale trial on November 23, a large-scale trial shows that a vaccine developed by Oxford University can prevent 70% of people from being infected with the novel coronavirus. The UK government has ordered 100 million doses of the Oxford coronavirus vaccine, and residents and employees in nursing homes will be the first to be vaccinated.
Previously, pharmaceutical company Moderna said its coronavirus vaccine was effective at 94.5%, while pharmaceutical company Pfizer said its coronavirus vaccine was effective at 95%. Compared with both, Oxford vaccine is slightly less efficient.
The BBC reported that compared with both, Oxford vaccines are cheaper and easier to store, and easier to reach all corners of the world. If approved, the Oxford vaccine will still play a major role in stopping the coronavirus pandemic. Oxford University researchers spent about 10 months developing the vaccine, usually 10 years.
More than 20,000 people participated in the trial of the vaccine, half in the United Kingdom and the other half in Brazil. Of the cases of COVID-19, 30 were given two doses of vaccine and another 101 were given placebo. The researchers said that the protective effect of the vaccine is 70%.
The report said that the British government has ordered 100 million doses of Oxford vaccine, enough to vaccinated 50 million people. Four million doses of vaccines are available in the UK, and another 96 million doses are still waiting to be delivered. Vaccinations will not be carried out until the regulatory authorities approve it. The regulatory authority will evaluate the safety, effectiveness and high production standards of vaccines. These will be carried out next week.
The British government is ready to launch this unprecedented large-scale immunization program, which dwarfs the annual influenza and child immunization programs. Residents and employees of nursing homes will be first vaccinated, followed by medical staff and seniors over 85 years old, and then the age limit will be gradually relaxed.
According to Reuters on November 19th local time, data released on Thursday showed that AstraZeneca’s research on a coronavirus vaccine in cooperation with Oxford University has produced a strong immune response in the elderly.
The data was released in part last month, but it was released in full on The Lancet on Thursday. Data show that older people over 70 years old are at higher risk of severe COVID-19 and death. “It’s really encouraging to see strong antibody and T-cell responses in older adults in our studies,” said Mahesh Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group.
According to a BBC local time report on November 22, nursing homes have been seriously affected by the novel coronavirus pneumonia. In order to protect the residents of nursing homes from infection, nursing homes are recommended to impose strict visiting restrictions.
Of the 483 nursing homes in Northern Ireland, nearly 30% (143) are dealing with the coronavirus outbreak. Nursing home residents account for more than 40% of the coronavirus-related deaths in Northern Ireland.
According to the latest guidance of the British Health Department, reducing abortion in nursing homes is considered one of the most effective measures to avoid infection.